The summary below was generated by an AI language model and may contain errors or omissions. All other content on this page is deterministically extracted from the original SEC EDGAR filing.
Amgen Inc. maintained complete structural stability in its Risk Factors section between the 2024 and 2025 10-K filings, with all six risks remaining substantively unchanged. No new risk disclosures were added and no previously disclosed risks were removed. This consistency indicates that Amgen's identified material risk landscape did not shift materially between the two reporting periods.
Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.